姓 名: |
赵琼雅 |
工作单位: |
检验医学院、生物工程学院 |
|
职 称: |
副教授 |
职 务: |
||
办公电话: |
无 |
邮 箱: |
qiongyazhao@gmail.com |
|
学科专业: |
公共卫生与预防医学 |
|||
研究方向: |
线粒体功能调控与糖脂代谢 |
从事线粒体功能调控在慢性代谢性疾病发生发展中的作用与机制研究。近五年来,以第一或者共同第一作者的身份发表多篇文献探究线粒体基因或功能紊乱在慢性代谢病发生过程中的作用机制(Diabetes 2022, 2018 等)。相关研究以项目主持人身份获得国家自然科学基金青年项目和浙江省自然科学基金探索项目的支持。
·研究生/博士:2013 年9 月-2019年7月,温州医科大学,临床检验诊断学专业;
·本科/学士:2009 年9 月-2013 年7 月,鞍山师范学院,生物科学(师范)专业。
2019.09-2021.11,杭州医学院,检验医学院,讲师;
2021.11-2022.12,杭州医学院,检验医学院、生物工程学院,讲师;
2023.01-至今,杭州医学院,检验医学院、生物工程学院,副教授;
2023.10.18-至今,浙江省医学会检验医学分会第十届委员会青年委员
1. COX7A2L调控线粒体代谢介导MAFLD发生发展的机制及标志物价值研究,国家自然科学基金面上项目,2024年-2027年;
2. RAP1调控线粒体自噬影响代谢性脂肪肝病发生发展的研究,国家自然科学基金青年基金项目,2022 年-2024 年;
3. COX7A2L调控棕色脂肪组织产热影响机体代谢的机制研究,,浙江省自然科学基金探索项目,2022 年-2024年
4. COX7A2L参与线粒体超级复合体组装影响肝脏脂质代谢调节肥胖的作用与机制研究,杭州医学院基本科研业务费基础科研计划-重点科研基金项目,2022年-2024年
(1) Yongjie Zhang, Yangli Wang, Xin Liao, Tong Liu, Fengyuan Yang, Kaiqiang Yang, Zhuohua Zhou,Yinxu Fu, Ting Fu, Aliaksei Sysa, Xiandan Chen, Yao Shen*, Jianxin Lyu* and Qiongya Zhao*; Glutamine prevents high?fat diet?induced hepatic lipid accumulation in mice by modulating lipolysis and oxidative stress. Nutrition & Metabolism. 2024. 21:12.
(2) Miaomiao Du; Xueyun Li; Fangyi Xiao; Yinxu Fu; Yu Shi; Sihan Guo; Lifang Chen; Lu Shen; Lan Wang; Huang Cheng; Hao Li; Anran Xie; Yaping Zhou; Kaiqiang Yang; Hezhi Fang; Jianxin Lyu; Qiongya Zhao ;Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice, Metabolism-clinical and Experimental, 2022, 134: 155244-155244;
(3) Qiongya Zhao#; Ting Luo#; Feng Gao#; Yinxu Fu; Bin Li; Xiaoli Shao; Haifeng Chen; Zhuohua Zhou; Sihan Guo; Lijun Shen; Liqin Jin; Dong Cen; Huaibin Zhou*; Jianxin Lyu*; Hezhi Fang* ; GRP75 Regulates Mitochondrial-Supercomplex Turnover to Modulate Insulin Sensitivity, Diabetes, 2022, 71: 233-248;
(4) Zhao, Qiong-Ya#; Ge, Ling-Hong#; Zhang, Kun#; Chen, Hai-Feng; Zhan, Xin-Xin; Yang, Yue; Dang , Qing-Lin; Zheng, Yi; Zhou, Huai-Bin*; Lyu, Jian-Xin*; Fang, He-Zhi* ; Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models, ZOOLOG ICAL RESEARCH, 2020, 41(5): 539-551;
(5) Chen, Deyu#; Zhao Qiongya#; Xiong, Jingting#; Lou, Xiaoting; Han, Qinxia; Wei, Xiujuan; Xie , Jie; Li, Xueyun; Zhou, Huaibin; Shen, Lijun; Yang, Yanling*; Fang, Hezhi*; Lyu, Jianxin* ; Systematic analysis of a mitochondrial disease-causing ND6 mutation in mitochondrial deficiency, Molecular Genetics & Genomic Medicine, 2020, 8(5): 0-e1199.
(6) Hua, Shixuan#; Li, Meinan#; Zhao, Qiongya#; Wang, Junyi; Zhou, Yaping; Liu, Jiangtao; Fang,Hezhi; Jiang, Minghua*; Shen, Lijun* ; Mitochondrial DNA Haplogroup N9a Negatively Correlates with Incidence of Hepatocellular Carcinoma in Northern China, Molecular Therapy - Nucleic Acids, 2019, 18: 332-340;
(7) Fang Hezhi#; Hu Nianqi#; Zhao Qiongya#; Wang Bingqian#; Zhou Huaibin; Fu Qingzi; Shen Lijun; Chen Xiong; Shen Feixia; Lyu Jianxin* ; mtDNA Haplogroup N9a Increases the Risk of Type 2 Diabetes by Altering Mitochondrial Function and Intracellular Mitochondrial Signals, Diabetes, 2018, 67(7) : 1441-1453;